Validating new reagents: Roadmaps through the wilderness

Laboratory Medicine

Volumn 37, Issue 6, 2006, Pages 347-351

  Martindale, Roberta A ^a   Cembrowski, George S ^a,b   Journault, Lucille J ^a,b   Crawford, Jennifer L ^a,b   Tran, Chi ^a,b   Hofer, Tammy L ^a,b   Rintoul, Bev J ^a,b   Der, Jean S ^a,b   Revers, Cathy W ^a,b   Vesso, Cheryl A ^a,b   Shalapay, Carol E ^a,b   Prosser, Connie I ^a,b   Legatt, Donald F ^a,b  

^a UNIVERSITY OF ALBERTA HOSPITAL   (Canada)

^b Capital Health Edmonton   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

REAGENT;

ACCURACY; ALGORITHM; ANALYTICAL EQUIPMENT; ANALYTICAL ERROR; ARTICLE; CLINICAL LABORATORY; INSTRUMENT VALIDATION; LABORATORY PERSONNEL; LABORATORY TEST; PATIENT CODING; QUALITY CONTROL; REAGENT LOT; VALIDATION PROCESS;

EID: 33744503665     PISSN: 00075027     EISSN: None     Source Type: Journal    
DOI: 10.1309/BRC6Y37NM3BU97WX     Document Type: Article

References (13)

1. Fuchs PC, Barry AL, Brown SD, et al. Intrepretive criteria and quality control parameters for testing of susceptibilities of Haemophilus influenzae and Streptococcus pneumoniae to trimethoprim and trimethoprim-sulfamethoxazole. J Clin Microbiol. 1997;35:125-131.
2. Houdijk WP. Warning: Simplate II, lack of standardization in standardized bleeding time devices-reply: Lot-to-lot variation in ejection force has been rectified. Thromb Haemost. 1991;66:625-626.
3. Anonymous. COULTER lyse S III diff: Reagent lot gives erroneous results. Health Devices. 1991;20:445-446.
4. Carey RN, Frye RM, Cook JD, et al. Between-lot/between-instrument variations of the Abbott IMx method for prostate-specific antigen. Clin Chem. 1992;38:2341-2343.
5. Wener MH, Daum PR, Brawer MK. Variation in measurement of prostate-specific antigen: importance of method and lot variability. Clin Chem. 1995;41:1730-1737.
6. Dufour DR. Lot-to-lot variation in anti-hepatitis C signal-to-cutoff ratio. Clin Chem. 2004;50:958-960.
7. Goodman DB, Bulley M, Hendricks M, et al. Assessment of the Abbott IMx assay system for the measurement of human chorionic gonadotropin levels in the treatment of ectopic pregnancy. Arch Pathol Lab Med. 1993;117:701-703.
8. Cembrowski GS, Carey NR. Laboratory Quality Management. Chicago: ASCP Press, 1989:102-103.
9. Gottschling HD, Reuter W, Ronquist G, et al. Multicentre evaluation of a non-wipe system for the rapid determination of total cholesterol in capillary blood. Accutrend cholesterol on Accutrend GC. Eur J Clin Chem Clin Biochem. 1995;33:373-381.
10. Boerma GJ, Gelderland J, van Gorp I, et al. Use of the Reflotron system for cholesterol assay in capillary blood, venous blood, and serum-evaluation of accuracy and lot-to-lot reagent comparability. Clin Chem. 1988;34:2117-2119.
11. Hill SA, Heathcote JC, McQueen MJ. The significance of matrix effects on the measurement of lactate dehydrogenase (LD) activity using Kodak dry slide technology in the Ontario Laboratory Proficiency Testing Program. Clin Biochem. 1990;23:179-181.
12. Department of Health & Human Services Health Care Financing Administration Public Health Service 42 CFR Part 405, et al. Clinical Laboratory Improvement Amendments of 1988; final rule. Federal Register Friday February 28, 1992.
13. Ricos C, Alvarez V, Cava F, et al. Current databases on biologic variation: pros, cons and progress. Scand J Clin Lab Invest. 1999;59:491-500. (updated in http://www.westgard.com/biodatabase1.htm)